chr1-43736265-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_006279.5(ST3GAL3):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
ST3GAL3
NM_006279.5 start_lost
NM_006279.5 start_lost
Scores
7
6
3
Clinical Significance
Conservation
PhyloP100: 6.71
Genes affected
ST3GAL3 (HGNC:10866): (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST3GAL3 | NM_006279.5 | c.3G>A | p.Met1? | start_lost | 2/12 | ENST00000347631.8 | NP_006270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST3GAL3 | ENST00000347631.8 | c.3G>A | p.Met1? | start_lost | 2/12 | 5 | NM_006279.5 | ENSP00000317192.6 | ||
ENSG00000284989 | ENST00000645057.1 | n.*1325G>A | non_coding_transcript_exon_variant | 16/26 | ENSP00000494063.1 | |||||
ENSG00000284989 | ENST00000645057.1 | n.*1325G>A | 3_prime_UTR_variant | 16/26 | ENSP00000494063.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 03, 2022 | This variant has not been reported in the literature in individuals affected with ST3GAL3-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1402972). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the ST3GAL3 mRNA. The next in-frame methionine is located at codon 95. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D;.;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
PROVEAN
Benign
N;N;N;D;N;N;N;.;.;.;N;.;N;.;N;.;.;N;.;N;.;.;N;.;N;D;N;N;N;N;D;N;D;N
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;D;D;D;.;.;.;D;.;D;.;D;.;.;D;.;D;.;.;D;.;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;.;.;.;D;.;D;.;D;.;.;D;.;D;.;.;D;.;D;D;D;D;D;D;D;D;D;D
Polyphen
P;P;P;.;P;P;P;.;.;.;.;.;P;P;P;P;.;D;.;.;.;P;.;.;P;P;P;P;.;P;P;P;.;P
Vest4
MutPred
Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);Gain of catalytic residue at M1 (P = 0.0062);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.